nodes	percent_of_prediction	percent_of_DWPC	metapath
Neostigmine—BCHE—Triamcinolone—psoriasis	0.27	0.398	CbGbCtD
Neostigmine—ABCB1—Mycophenolate mofetil—psoriasis	0.0686	0.101	CbGbCtD
Neostigmine—ABCB1—Betamethasone—psoriasis	0.0589	0.0866	CbGbCtD
Neostigmine—ABCB1—Prednisolone—psoriasis	0.0581	0.0855	CbGbCtD
Neostigmine—ABCB1—Hydrocortisone—psoriasis	0.055	0.081	CbGbCtD
Neostigmine—ABCB1—Prednisone—psoriasis	0.0548	0.0807	CbGbCtD
Neostigmine—ABCB1—Cyclosporine—psoriasis	0.052	0.0765	CbGbCtD
Neostigmine—ABCB1—Dexamethasone—psoriasis	0.0342	0.0504	CbGbCtD
Neostigmine—ABCB1—Methotrexate—psoriasis	0.0275	0.0405	CbGbCtD
Neostigmine—Arrhythmia—Triamcinolone—psoriasis	0.00046	0.00144	CcSEcCtD
Neostigmine—Loss of consciousness—Mycophenolate mofetil—psoriasis	0.00046	0.00143	CcSEcCtD
Neostigmine—Arthralgia—Cyclosporine—psoriasis	0.000456	0.00142	CcSEcCtD
Neostigmine—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—psoriasis	0.000453	0.00141	CcSEcCtD
Neostigmine—Convulsion—Mycophenolate mofetil—psoriasis	0.000453	0.00141	CcSEcCtD
Neostigmine—Dry mouth—Cyclosporine—psoriasis	0.000446	0.00139	CcSEcCtD
Neostigmine—Arthralgia—Mycophenolate mofetil—psoriasis	0.000445	0.00139	CcSEcCtD
Neostigmine—Gastrointestinal pain—Mycophenolic acid—psoriasis	0.000442	0.00138	CcSEcCtD
Neostigmine—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—psoriasis	0.000442	0.00138	CcSEcCtD
Neostigmine—Diarrhoea—Hydroxyurea—psoriasis	0.000442	0.00138	CcSEcCtD
Neostigmine—Anaphylactic shock—Cyclosporine—psoriasis	0.000437	0.00136	CcSEcCtD
Neostigmine—Syncope—Prednisolone—psoriasis	0.000437	0.00136	CcSEcCtD
Neostigmine—Dry mouth—Mycophenolate mofetil—psoriasis	0.000435	0.00136	CcSEcCtD
Neostigmine—Nervous system disorder—Cyclosporine—psoriasis	0.000429	0.00134	CcSEcCtD
Neostigmine—Loss of consciousness—Prednisolone—psoriasis	0.000429	0.00134	CcSEcCtD
Neostigmine—Abdominal pain—Mycophenolic acid—psoriasis	0.000427	0.00133	CcSEcCtD
Neostigmine—Syncope—Hydrocortisone—psoriasis	0.000427	0.00133	CcSEcCtD
Neostigmine—Dizziness—Hydroxyurea—psoriasis	0.000427	0.00133	CcSEcCtD
Neostigmine—Anaphylactic shock—Mycophenolate mofetil—psoriasis	0.000427	0.00133	CcSEcCtD
Neostigmine—Skin disorder—Cyclosporine—psoriasis	0.000425	0.00133	CcSEcCtD
Neostigmine—Hyperhidrosis—Cyclosporine—psoriasis	0.000423	0.00132	CcSEcCtD
Neostigmine—Convulsion—Prednisolone—psoriasis	0.000423	0.00132	CcSEcCtD
Neostigmine—Shock—Mycophenolate mofetil—psoriasis	0.00042	0.00131	CcSEcCtD
Neostigmine—Loss of consciousness—Hydrocortisone—psoriasis	0.000419	0.00131	CcSEcCtD
Neostigmine—Nervous system disorder—Mycophenolate mofetil—psoriasis	0.000418	0.00131	CcSEcCtD
Neostigmine—Arrhythmia—Dexamethasone—psoriasis	0.000418	0.0013	CcSEcCtD
Neostigmine—Arrhythmia—Betamethasone—psoriasis	0.000418	0.0013	CcSEcCtD
Neostigmine—Tachycardia—Mycophenolate mofetil—psoriasis	0.000416	0.0013	CcSEcCtD
Neostigmine—Skin disorder—Mycophenolate mofetil—psoriasis	0.000414	0.00129	CcSEcCtD
Neostigmine—Bradycardia—Prednisone—psoriasis	0.000414	0.00129	CcSEcCtD
Neostigmine—Convulsion—Hydrocortisone—psoriasis	0.000413	0.00129	CcSEcCtD
Neostigmine—Hyperhidrosis—Mycophenolate mofetil—psoriasis	0.000412	0.00129	CcSEcCtD
Neostigmine—Vomiting—Hydroxyurea—psoriasis	0.00041	0.00128	CcSEcCtD
Neostigmine—Rash—Hydroxyurea—psoriasis	0.000407	0.00127	CcSEcCtD
Neostigmine—Dermatitis—Hydroxyurea—psoriasis	0.000407	0.00127	CcSEcCtD
Neostigmine—Headache—Hydroxyurea—psoriasis	0.000404	0.00126	CcSEcCtD
Neostigmine—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—psoriasis	0.000403	0.00126	CcSEcCtD
Neostigmine—Syncope—Triamcinolone—psoriasis	0.000402	0.00125	CcSEcCtD
Neostigmine—Connective tissue disorder—Prednisone—psoriasis	0.0004	0.00125	CcSEcCtD
Neostigmine—Hypotension—Mycophenolate mofetil—psoriasis	0.000399	0.00124	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Cyclosporine—psoriasis	0.000399	0.00124	CcSEcCtD
Neostigmine—Anaphylactic shock—Prednisolone—psoriasis	0.000398	0.00124	CcSEcCtD
Neostigmine—Insomnia—Cyclosporine—psoriasis	0.000396	0.00123	CcSEcCtD
Neostigmine—Loss of consciousness—Triamcinolone—psoriasis	0.000394	0.00123	CcSEcCtD
Neostigmine—Shock—Prednisolone—psoriasis	0.000392	0.00122	CcSEcCtD
Neostigmine—Dyspnoea—Cyclosporine—psoriasis	0.00039	0.00122	CcSEcCtD
Neostigmine—Somnolence—Cyclosporine—psoriasis	0.000389	0.00121	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Mycophenolate mofetil—psoriasis	0.000389	0.00121	CcSEcCtD
Neostigmine—Anaphylactic shock—Hydrocortisone—psoriasis	0.000389	0.00121	CcSEcCtD
Neostigmine—Convulsion—Triamcinolone—psoriasis	0.000389	0.00121	CcSEcCtD
Neostigmine—Tachycardia—Prednisolone—psoriasis	0.000388	0.00121	CcSEcCtD
Neostigmine—Asthenia—Mycophenolic acid—psoriasis	0.000388	0.00121	CcSEcCtD
Neostigmine—Insomnia—Mycophenolate mofetil—psoriasis	0.000386	0.0012	CcSEcCtD
Neostigmine—Hyperhidrosis—Prednisolone—psoriasis	0.000385	0.0012	CcSEcCtD
Neostigmine—Nausea—Hydroxyurea—psoriasis	0.000383	0.0012	CcSEcCtD
Neostigmine—Pruritus—Mycophenolic acid—psoriasis	0.000383	0.00119	CcSEcCtD
Neostigmine—Shock—Hydrocortisone—psoriasis	0.000382	0.00119	CcSEcCtD
Neostigmine—Nervous system disorder—Hydrocortisone—psoriasis	0.000381	0.00119	CcSEcCtD
Neostigmine—Dyspnoea—Mycophenolate mofetil—psoriasis	0.00038	0.00119	CcSEcCtD
Neostigmine—Tachycardia—Hydrocortisone—psoriasis	0.000379	0.00118	CcSEcCtD
Neostigmine—Somnolence—Mycophenolate mofetil—psoriasis	0.000379	0.00118	CcSEcCtD
Neostigmine—Drowsiness—Methotrexate—psoriasis	0.000379	0.00118	CcSEcCtD
Neostigmine—Flushing—Prednisone—psoriasis	0.000378	0.00118	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Cyclosporine—psoriasis	0.000378	0.00118	CcSEcCtD
Neostigmine—Skin disorder—Hydrocortisone—psoriasis	0.000378	0.00118	CcSEcCtD
Neostigmine—Hyperhidrosis—Hydrocortisone—psoriasis	0.000376	0.00117	CcSEcCtD
Neostigmine—Dry mouth—Triamcinolone—psoriasis	0.000373	0.00116	CcSEcCtD
Neostigmine—Diarrhoea—Mycophenolic acid—psoriasis	0.00037	0.00115	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	0.000368	0.00115	CcSEcCtD
Neostigmine—Anaphylactic shock—Triamcinolone—psoriasis	0.000366	0.00114	CcSEcCtD
Neostigmine—Syncope—Dexamethasone—psoriasis	0.000365	0.00114	CcSEcCtD
Neostigmine—Syncope—Betamethasone—psoriasis	0.000365	0.00114	CcSEcCtD
Neostigmine—Arrhythmia—Prednisone—psoriasis	0.000364	0.00113	CcSEcCtD
Neostigmine—Hypotension—Hydrocortisone—psoriasis	0.000363	0.00113	CcSEcCtD
Neostigmine—Shock—Triamcinolone—psoriasis	0.00036	0.00112	CcSEcCtD
Neostigmine—Insomnia—Prednisolone—psoriasis	0.00036	0.00112	CcSEcCtD
Neostigmine—Gastrointestinal pain—Cyclosporine—psoriasis	0.000358	0.00112	CcSEcCtD
Neostigmine—Loss of consciousness—Dexamethasone—psoriasis	0.000358	0.00112	CcSEcCtD
Neostigmine—Loss of consciousness—Betamethasone—psoriasis	0.000358	0.00112	CcSEcCtD
Neostigmine—Dizziness—Mycophenolic acid—psoriasis	0.000358	0.00112	CcSEcCtD
Neostigmine—Tachycardia—Triamcinolone—psoriasis	0.000357	0.00111	CcSEcCtD
Neostigmine—Mental disorder—Prednisone—psoriasis	0.000357	0.00111	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Hydrocortisone—psoriasis	0.000354	0.0011	CcSEcCtD
Neostigmine—Hyperhidrosis—Triamcinolone—psoriasis	0.000354	0.0011	CcSEcCtD
Neostigmine—Convulsion—Betamethasone—psoriasis	0.000353	0.0011	CcSEcCtD
Neostigmine—Convulsion—Dexamethasone—psoriasis	0.000353	0.0011	CcSEcCtD
Neostigmine—Insomnia—Hydrocortisone—psoriasis	0.000352	0.0011	CcSEcCtD
Neostigmine—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	0.000349	0.00109	CcSEcCtD
Neostigmine—Urticaria—Cyclosporine—psoriasis	0.000347	0.00108	CcSEcCtD
Neostigmine—Abdominal pain—Cyclosporine—psoriasis	0.000346	0.00108	CcSEcCtD
Neostigmine—Vomiting—Mycophenolic acid—psoriasis	0.000344	0.00107	CcSEcCtD
Neostigmine—Rash—Mycophenolic acid—psoriasis	0.000341	0.00106	CcSEcCtD
Neostigmine—Dermatitis—Mycophenolic acid—psoriasis	0.000341	0.00106	CcSEcCtD
Neostigmine—Urticaria—Mycophenolate mofetil—psoriasis	0.000339	0.00106	CcSEcCtD
Neostigmine—Headache—Mycophenolic acid—psoriasis	0.000339	0.00106	CcSEcCtD
Neostigmine—Abdominal pain—Mycophenolate mofetil—psoriasis	0.000337	0.00105	CcSEcCtD
Neostigmine—Urinary tract disorder—Methotrexate—psoriasis	0.000336	0.00105	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Hydrocortisone—psoriasis	0.000336	0.00105	CcSEcCtD
Neostigmine—Urethral disorder—Methotrexate—psoriasis	0.000334	0.00104	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Triamcinolone—psoriasis	0.000333	0.00104	CcSEcCtD
Neostigmine—Anaphylactic shock—Betamethasone—psoriasis	0.000332	0.00104	CcSEcCtD
Neostigmine—Anaphylactic shock—Dexamethasone—psoriasis	0.000332	0.00104	CcSEcCtD
Neostigmine—Insomnia—Triamcinolone—psoriasis	0.000331	0.00103	CcSEcCtD
Neostigmine—Shock—Betamethasone—psoriasis	0.000327	0.00102	CcSEcCtD
Neostigmine—Shock—Dexamethasone—psoriasis	0.000327	0.00102	CcSEcCtD
Neostigmine—Dyspnoea—Triamcinolone—psoriasis	0.000326	0.00102	CcSEcCtD
Neostigmine—Nervous system disorder—Dexamethasone—psoriasis	0.000326	0.00102	CcSEcCtD
Neostigmine—Nervous system disorder—Betamethasone—psoriasis	0.000326	0.00102	CcSEcCtD
Neostigmine—Agitation—Prednisone—psoriasis	0.000326	0.00102	CcSEcCtD
Neostigmine—Tachycardia—Betamethasone—psoriasis	0.000324	0.00101	CcSEcCtD
Neostigmine—Tachycardia—Dexamethasone—psoriasis	0.000324	0.00101	CcSEcCtD
Neostigmine—Hypersensitivity—Cyclosporine—psoriasis	0.000322	0.00101	CcSEcCtD
Neostigmine—Nausea—Mycophenolic acid—psoriasis	0.000321	0.001	CcSEcCtD
Neostigmine—Hyperhidrosis—Dexamethasone—psoriasis	0.000321	0.001	CcSEcCtD
Neostigmine—Hyperhidrosis—Betamethasone—psoriasis	0.000321	0.001	CcSEcCtD
Neostigmine—Gastrointestinal pain—Hydrocortisone—psoriasis	0.000318	0.000992	CcSEcCtD
Neostigmine—Syncope—Prednisone—psoriasis	0.000318	0.000991	CcSEcCtD
Neostigmine—Urticaria—Prednisolone—psoriasis	0.000316	0.000986	CcSEcCtD
Neostigmine—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.000314	0.000981	CcSEcCtD
Neostigmine—Asthenia—Cyclosporine—psoriasis	0.000314	0.000979	CcSEcCtD
Neostigmine—Loss of consciousness—Prednisone—psoriasis	0.000311	0.000972	CcSEcCtD
Neostigmine—Hypotension—Dexamethasone—psoriasis	0.00031	0.000968	CcSEcCtD
Neostigmine—Hypotension—Betamethasone—psoriasis	0.00031	0.000968	CcSEcCtD
Neostigmine—Pruritus—Cyclosporine—psoriasis	0.000309	0.000965	CcSEcCtD
Neostigmine—Urticaria—Hydrocortisone—psoriasis	0.000309	0.000963	CcSEcCtD
Neostigmine—Abdominal pain—Hydrocortisone—psoriasis	0.000307	0.000959	CcSEcCtD
Neostigmine—Convulsion—Prednisone—psoriasis	0.000307	0.000958	CcSEcCtD
Neostigmine—Mediastinal disorder—Methotrexate—psoriasis	0.000307	0.000957	CcSEcCtD
Neostigmine—Asthenia—Mycophenolate mofetil—psoriasis	0.000306	0.000955	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Dexamethasone—psoriasis	0.000303	0.000944	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Betamethasone—psoriasis	0.000303	0.000944	CcSEcCtD
Neostigmine—Pruritus—Mycophenolate mofetil—psoriasis	0.000302	0.000942	CcSEcCtD
Neostigmine—Arthralgia—Prednisone—psoriasis	0.000302	0.000941	CcSEcCtD
Neostigmine—Insomnia—Betamethasone—psoriasis	0.0003	0.000937	CcSEcCtD
Neostigmine—Insomnia—Dexamethasone—psoriasis	0.0003	0.000937	CcSEcCtD
Neostigmine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	0.0003	0.000935	CcSEcCtD
Neostigmine—Diarrhoea—Cyclosporine—psoriasis	0.000299	0.000934	CcSEcCtD
Neostigmine—Mental disorder—Methotrexate—psoriasis	0.000298	0.00093	CcSEcCtD
Neostigmine—Hypersensitivity—Prednisolone—psoriasis	0.000293	0.000915	CcSEcCtD
Neostigmine—Diarrhoea—Mycophenolate mofetil—psoriasis	0.000292	0.000911	CcSEcCtD
Neostigmine—Urticaria—Triamcinolone—psoriasis	0.000291	0.000907	CcSEcCtD
Neostigmine—Dizziness—Cyclosporine—psoriasis	0.000289	0.000902	CcSEcCtD
Neostigmine—Anaphylactic shock—Prednisone—psoriasis	0.000289	0.000902	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Betamethasone—psoriasis	0.000287	0.000894	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Dexamethasone—psoriasis	0.000287	0.000894	CcSEcCtD
Neostigmine—Hypersensitivity—Hydrocortisone—psoriasis	0.000286	0.000893	CcSEcCtD
Neostigmine—Shock—Prednisone—psoriasis	0.000285	0.000888	CcSEcCtD
Neostigmine—Nervous system disorder—Prednisone—psoriasis	0.000284	0.000885	CcSEcCtD
Neostigmine—Tachycardia—Prednisone—psoriasis	0.000282	0.000881	CcSEcCtD
Neostigmine—Dizziness—Mycophenolate mofetil—psoriasis	0.000282	0.00088	CcSEcCtD
Neostigmine—Skin disorder—Prednisone—psoriasis	0.000281	0.000876	CcSEcCtD
Neostigmine—Hyperhidrosis—Prednisone—psoriasis	0.00028	0.000872	CcSEcCtD
Neostigmine—Asthenia—Hydrocortisone—psoriasis	0.000279	0.00087	CcSEcCtD
Neostigmine—Vomiting—Cyclosporine—psoriasis	0.000278	0.000868	CcSEcCtD
Neostigmine—Rash—Cyclosporine—psoriasis	0.000276	0.00086	CcSEcCtD
Neostigmine—Dermatitis—Cyclosporine—psoriasis	0.000276	0.00086	CcSEcCtD
Neostigmine—Pruritus—Hydrocortisone—psoriasis	0.000275	0.000858	CcSEcCtD
Neostigmine—Headache—Cyclosporine—psoriasis	0.000274	0.000855	CcSEcCtD
Neostigmine—Gastrointestinal pain—Betamethasone—psoriasis	0.000272	0.000847	CcSEcCtD
Neostigmine—Gastrointestinal pain—Dexamethasone—psoriasis	0.000272	0.000847	CcSEcCtD
Neostigmine—Vomiting—Mycophenolate mofetil—psoriasis	0.000271	0.000846	CcSEcCtD
Neostigmine—Hypersensitivity—Triamcinolone—psoriasis	0.00027	0.000841	CcSEcCtD
Neostigmine—Rash—Mycophenolate mofetil—psoriasis	0.000269	0.000839	CcSEcCtD
Neostigmine—Dermatitis—Mycophenolate mofetil—psoriasis	0.000269	0.000838	CcSEcCtD
Neostigmine—Headache—Mycophenolate mofetil—psoriasis	0.000267	0.000834	CcSEcCtD
Neostigmine—Diarrhoea—Hydrocortisone—psoriasis	0.000266	0.00083	CcSEcCtD
Neostigmine—Urticaria—Dexamethasone—psoriasis	0.000264	0.000823	CcSEcCtD
Neostigmine—Urticaria—Betamethasone—psoriasis	0.000264	0.000823	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Prednisone—psoriasis	0.000264	0.000822	CcSEcCtD
Neostigmine—Dizziness—Prednisolone—psoriasis	0.000263	0.000821	CcSEcCtD
Neostigmine—Asthenia—Triamcinolone—psoriasis	0.000263	0.000819	CcSEcCtD
Neostigmine—Abdominal pain—Betamethasone—psoriasis	0.000263	0.000819	CcSEcCtD
Neostigmine—Abdominal pain—Dexamethasone—psoriasis	0.000263	0.000819	CcSEcCtD
Neostigmine—Insomnia—Prednisone—psoriasis	0.000262	0.000816	CcSEcCtD
Neostigmine—Nausea—Cyclosporine—psoriasis	0.00026	0.000811	CcSEcCtD
Neostigmine—Pruritus—Triamcinolone—psoriasis	0.000259	0.000808	CcSEcCtD
Neostigmine—Dizziness—Hydrocortisone—psoriasis	0.000257	0.000802	CcSEcCtD
Neostigmine—Convulsion—Methotrexate—psoriasis	0.000257	0.000801	CcSEcCtD
Neostigmine—Nausea—Mycophenolate mofetil—psoriasis	0.000253	0.000791	CcSEcCtD
Neostigmine—Arthralgia—Methotrexate—psoriasis	0.000252	0.000787	CcSEcCtD
Neostigmine—Rash—Prednisolone—psoriasis	0.000251	0.000783	CcSEcCtD
Neostigmine—Dermatitis—Prednisolone—psoriasis	0.000251	0.000782	CcSEcCtD
Neostigmine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	0.00025	0.000781	CcSEcCtD
Neostigmine—Headache—Prednisolone—psoriasis	0.000249	0.000778	CcSEcCtD
Neostigmine—Vomiting—Hydrocortisone—psoriasis	0.000247	0.000771	CcSEcCtD
Neostigmine—Rash—Hydrocortisone—psoriasis	0.000245	0.000765	CcSEcCtD
Neostigmine—Dermatitis—Hydrocortisone—psoriasis	0.000245	0.000764	CcSEcCtD
Neostigmine—Headache—Hydrocortisone—psoriasis	0.000244	0.00076	CcSEcCtD
Neostigmine—Dizziness—Triamcinolone—psoriasis	0.000242	0.000755	CcSEcCtD
Neostigmine—Anaphylactic shock—Methotrexate—psoriasis	0.000242	0.000754	CcSEcCtD
Neostigmine—Asthenia—Dexamethasone—psoriasis	0.000238	0.000743	CcSEcCtD
Neostigmine—Asthenia—Betamethasone—psoriasis	0.000238	0.000743	CcSEcCtD
Neostigmine—Nervous system disorder—Methotrexate—psoriasis	0.000237	0.000739	CcSEcCtD
Neostigmine—Gastrointestinal pain—Prednisone—psoriasis	0.000237	0.000738	CcSEcCtD
Neostigmine—Nausea—Prednisolone—psoriasis	0.000236	0.000738	CcSEcCtD
Neostigmine—Pruritus—Dexamethasone—psoriasis	0.000235	0.000733	CcSEcCtD
Neostigmine—Pruritus—Betamethasone—psoriasis	0.000235	0.000733	CcSEcCtD
Neostigmine—Skin disorder—Methotrexate—psoriasis	0.000235	0.000732	CcSEcCtD
Neostigmine—Hyperhidrosis—Methotrexate—psoriasis	0.000234	0.000729	CcSEcCtD
Neostigmine—Vomiting—Triamcinolone—psoriasis	0.000233	0.000726	CcSEcCtD
Neostigmine—Nausea—Hydrocortisone—psoriasis	0.000231	0.00072	CcSEcCtD
Neostigmine—Rash—Triamcinolone—psoriasis	0.000231	0.00072	CcSEcCtD
Neostigmine—Dermatitis—Triamcinolone—psoriasis	0.000231	0.000719	CcSEcCtD
Neostigmine—Urticaria—Prednisone—psoriasis	0.00023	0.000717	CcSEcCtD
Neostigmine—Headache—Triamcinolone—psoriasis	0.000229	0.000715	CcSEcCtD
Neostigmine—Abdominal pain—Prednisone—psoriasis	0.000229	0.000713	CcSEcCtD
Neostigmine—Diarrhoea—Betamethasone—psoriasis	0.000227	0.000709	CcSEcCtD
Neostigmine—Diarrhoea—Dexamethasone—psoriasis	0.000227	0.000709	CcSEcCtD
Neostigmine—Hypotension—Methotrexate—psoriasis	0.000226	0.000705	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Methotrexate—psoriasis	0.00022	0.000687	CcSEcCtD
Neostigmine—Dizziness—Dexamethasone—psoriasis	0.00022	0.000685	CcSEcCtD
Neostigmine—Dizziness—Betamethasone—psoriasis	0.00022	0.000685	CcSEcCtD
Neostigmine—Insomnia—Methotrexate—psoriasis	0.000219	0.000682	CcSEcCtD
Neostigmine—Nausea—Triamcinolone—psoriasis	0.000217	0.000678	CcSEcCtD
Neostigmine—Dyspnoea—Methotrexate—psoriasis	0.000216	0.000672	CcSEcCtD
Neostigmine—Somnolence—Methotrexate—psoriasis	0.000215	0.00067	CcSEcCtD
Neostigmine—Hypersensitivity—Prednisone—psoriasis	0.000213	0.000665	CcSEcCtD
Neostigmine—Vomiting—Dexamethasone—psoriasis	0.000211	0.000659	CcSEcCtD
Neostigmine—Vomiting—Betamethasone—psoriasis	0.000211	0.000659	CcSEcCtD
Neostigmine—Rash—Betamethasone—psoriasis	0.000209	0.000653	CcSEcCtD
Neostigmine—Rash—Dexamethasone—psoriasis	0.000209	0.000653	CcSEcCtD
Neostigmine—Dermatitis—Dexamethasone—psoriasis	0.000209	0.000653	CcSEcCtD
Neostigmine—Dermatitis—Betamethasone—psoriasis	0.000209	0.000653	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Methotrexate—psoriasis	0.000209	0.000651	CcSEcCtD
Neostigmine—Headache—Dexamethasone—psoriasis	0.000208	0.000649	CcSEcCtD
Neostigmine—Headache—Betamethasone—psoriasis	0.000208	0.000649	CcSEcCtD
Neostigmine—Asthenia—Prednisone—psoriasis	0.000208	0.000647	CcSEcCtD
Neostigmine—Pruritus—Prednisone—psoriasis	0.000205	0.000638	CcSEcCtD
Neostigmine—Diarrhoea—Prednisone—psoriasis	0.000198	0.000617	CcSEcCtD
Neostigmine—Gastrointestinal pain—Methotrexate—psoriasis	0.000198	0.000617	CcSEcCtD
Neostigmine—Nausea—Betamethasone—psoriasis	0.000197	0.000615	CcSEcCtD
Neostigmine—Nausea—Dexamethasone—psoriasis	0.000197	0.000615	CcSEcCtD
Neostigmine—Urticaria—Methotrexate—psoriasis	0.000192	0.000599	CcSEcCtD
Neostigmine—Dizziness—Prednisone—psoriasis	0.000191	0.000597	CcSEcCtD
Neostigmine—Abdominal pain—Methotrexate—psoriasis	0.000191	0.000596	CcSEcCtD
Neostigmine—Vomiting—Prednisone—psoriasis	0.000184	0.000574	CcSEcCtD
Neostigmine—Rash—Prednisone—psoriasis	0.000182	0.000569	CcSEcCtD
Neostigmine—Dermatitis—Prednisone—psoriasis	0.000182	0.000568	CcSEcCtD
Neostigmine—Headache—Prednisone—psoriasis	0.000181	0.000565	CcSEcCtD
Neostigmine—Hypersensitivity—Methotrexate—psoriasis	0.000178	0.000556	CcSEcCtD
Neostigmine—Asthenia—Methotrexate—psoriasis	0.000173	0.000541	CcSEcCtD
Neostigmine—Nausea—Prednisone—psoriasis	0.000172	0.000536	CcSEcCtD
Neostigmine—Pruritus—Methotrexate—psoriasis	0.000171	0.000533	CcSEcCtD
Neostigmine—Diarrhoea—Methotrexate—psoriasis	0.000165	0.000516	CcSEcCtD
Neostigmine—Dizziness—Methotrexate—psoriasis	0.00016	0.000499	CcSEcCtD
Neostigmine—Vomiting—Methotrexate—psoriasis	0.000154	0.000479	CcSEcCtD
Neostigmine—Rash—Methotrexate—psoriasis	0.000152	0.000475	CcSEcCtD
Neostigmine—Dermatitis—Methotrexate—psoriasis	0.000152	0.000475	CcSEcCtD
Neostigmine—Headache—Methotrexate—psoriasis	0.000151	0.000472	CcSEcCtD
Neostigmine—Nausea—Methotrexate—psoriasis	0.000144	0.000448	CcSEcCtD
